Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
Onc.AI’s poster presentation showcases its FDA-breakthrough designated deep learning radiomics model, Serial CTRS, which evaluates changes across routine CT scans over time to predict overall survival ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results